The crystal structure of MPK38 in complex with OTSSP167, an orally administrative MELK selective inhibitor

Biochemical and Biophysical Research Communications

Volumn 447, Issue 1, 2014, Pages 7-11

  Cho, Yong Soon ^a   Kang, Yingjin ^a   Kim, Kuglae ^a   Cha, Young Je ^a   Cho, Hyun Soo ^a  

^a Yonsei University   (South Korea)

Author keywords

Inhibitors; MELK; MPK38; OTSSP167

Indexed keywords

1 (6 (3,5 DICHLORO 4 HYDROXYPHENYL) 4 ((TRANS 4 ((DIMETHYLAMINO)METHYL)CYCLOHEXYL)AMINO) 1,5 NAPHTHYRIDIN 3 YL)ETHANONE; MURINE PROTEIN SERINE THREONINE KINASE 38; OTSSP 167; PROTEIN SERINE THREONINE KINASE; PROTEIN SERINE THREONINE KINASE INHIBITOR; UNCLASSIFIED DRUG;

ARTICLE; BINDING AFFINITY; COMPLEX FORMATION; CRYSTAL STRUCTURE; DRUG PROTEIN BINDING; ENZYME ACTIVE SITE; PRIORITY JOURNAL; STRUCTURE ACTIVITY RELATION;

MURINAE;

INHIBITORS; MELK; MPK38; OTSSP167;

ANIMALS; CRYSTALLOGRAPHY, X-RAY; MICE; MODELS, MOLECULAR; NAPHTHYRIDINES; PROTEIN-SERINE-THREONINE KINASES;

EID: 84899491823     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2014.03.034     Document Type: Article

References (25)

1. M. Gil, Y. Yang, Y. Lee, I. Choi, and H. Ha Cloning and expression of a cDNA encoding a novel protein serine/threonine kinase predominantly expressed in hematopoietic cells Gene 195 1997 295 301
2. N. Davezac, V. Baldin, J. Blot, B. Ducommun, and J.P. Tassan Human pEg3 kinase associates with and phosphorylates CDC25B phosphatase: a potential role for pEg3 in cell cycle regulation Oncogene 21 2002 7630 7641
3. H. Jung, H.A. Seong, and H. Ha Murine protein serine/threonine kinase 38 activates apoptosis signal-regulating kinase 1 via Thr 838 phosphorylation J. Biol. Chem. 283 2008 34541 34553
4. M.L. Lin, J.H. Park, T. Nishidate, Y. Nakamura, and T. Katagiri Involvement of maternal embryonic leucine zipper kinase (MELK) in mammary carcinogenesis through interaction with Bcl-G, a pro-apoptotic member of the Bcl-2 family Breast Cancer Res. 9 2007 R17
5. V. Vulsteke, M. Beullens, A. Boudrez, S. Keppens, A. Van Eynde, M.H. Rider, W. Stalmans, and M. Bollen Inhibition of spliceosome assembly by the cell cycle-regulated protein kinase MELK and involvement of splicing factor NIPP1 J. Biol. Chem. 279 2004 8642 8647
6. I. Nakano, A.A. Paucar, R. Bajpai, J.D. Dougherty, A. Zewail, T.K. Kelly, K.J. Kim, J. Ou, M. Groszer, T. Imura, W.A. Freije, S.F. Nelson, M.V. Sofroniew, H. Wu, X. Liu, A.V. Terskikh, D.H. Geschwind, and H.I. Kornblum Maternal embryonic leucine zipper kinase (MELK) regulates multipotent neural progenitor proliferation J. Cell Biol. 170 2005 413 427
7. D. Gray, A.M. Jubb, D. Hogue, P. Dowd, N. Kljavin, S. Yi, W. Bai, G. Frantz, Z. Zhang, H. Koeppen, F.J. de Sauvage, and D.P. Davis Maternal embryonic leucine zipper kinase/murine protein serine-threonine kinase 38 is a promising therapeutic target for multiple cancers Cancer Res. 65 2005 9751 9761
8. I. Nakano, M. Masterman-Smith, K. Saigusa, A.A. Paucar, S. Horvath, L. Shoemaker, M. Watanabe, A. Negro, R. Bajpai, A. Howes, V. Lelievre, J.A. Waschek, J.A. Lazareff, W.A. Freije, L.M. Liau, R.J. Gilbertson, T.F. Cloughesy, D.H. Geschwind, S.F. Nelson, P.S. Mischel, A.V. Terskikh, and H.I. Kornblum Maternal embryonic leucine zipper kinase is a key regulator of the proliferation of malignant brain tumors, including brain tumor stem cells J. Neurosci. Res. 86 2008 48 60
9. M.R. Pickard, A.R. Green, I.O. Ellis, C. Caldas, V.L. Hedge, M. Mourtada-Maarabouni, and G.T. Williams Dysregulated expression of Fau and MELK is associated with poor prognosis in breast cancer Breast Cancer Res. 11 2009 R60
10. J.L. Ku, Y.K. Shin, D.W. Kim, K.H. Kim, J.S. Choi, S.H. Hong, Y.K. Jeon, S.H. Kim, H.S. Kim, J.H. Park, I.J. Kim, and J.G. Park Establishment and characterization of 13 human colorectal carcinoma cell lines: mutations of genes and expressions of drug-sensitivity genes and cancer stem cell markers Carcinogenesis 31 2010 1003 1009
11. G. Liu, X. Yuan, Z. Zeng, P. Tunici, H. Ng, I.R. Abdulkadir, L. Lu, D. Irvin, K.L. Black, and J.S. Yu Analysis of gene expression and chemoresistance of CD133+ cancer stem cells in glioblastoma Mol. Cancer 5 2006 67
12. B. Ryu, D.S. Kim, A.M. Deluca, and R.M. Alani Comprehensive expression profiling of tumor cell lines identifies molecular signatures of melanoma progression PLoS One 2 2007 e594
13. S.K. Marie, O.K. Okamoto, M. Uno, A.P. Hasegawa, S.M. Oba-Shinjo, T. Cohen, A.A. Camargo, A. Kosoy, C.G. Carlotti Jr., S. Toledo, C.A. Moreira-Filho, M.A. Zago, A.J. Simpson, and O.L. Caballero Maternal embryonic leucine zipper kinase transcript abundance correlates with malignancy grade in human astrocytomas Int. J. Cancer 122 2008 807 815
14. H.D. Hemmati, I. Nakano, J.A. Lazareff, M. Masterman-Smith, D.H. Geschwind, M. Bronner-Fraser, and H.I. Kornblum Cancerous stem cells can arise from pediatric brain tumors Proc. Natl. Acad. Sci. USA 100 2003 15178 15183
15. D.R. Rhodes, J. Yu, K. Shanker, N. Deshpande, R. Varambally, D. Ghosh, T. Barrette, A. Pandey, and A.M. Chinnaiyan Large-scale meta-analysis of cancer microarray data identifies common transcriptional profiles of neoplastic transformation and progression Proc. Natl. Acad. Sci. USA 101 2004 9309 9314
16. L.W. Hebbard, J. Maurer, A. Miller, J. Lesperance, J. Hassell, R.G. Oshima, and A.V. Terskikh Maternal embryonic leucine zipper kinase is upregulated and required in mammary tumor-initiating cells in vivo Cancer Res. 70 2010 8863 8873
17. B.D. Manning Challenges and opportunities in defining the essential cancer kinome Sci. Signal 2 2009 pe15
18. J. Brognard, and T. Hunter Protein kinase signaling networks in cancer Curr Opin Genet Dev 21 2011 4 11
19. S.W. Cowan-Jacob, H. Mobitz, and D. Fabbro Structural biology contributions to tyrosine kinase drug discovery Curr. Opin. Cell Biol. 21 2009 280 287
20. J. Zhang, P.L. Yang, and N.S. Gray Targeting cancer with small molecule kinase inhibitors Nat. Rev. Cancer 9 2009 28 39
21. S. Chung, H. Suzuki, T. Miyamoto, N. Takamatsu, A. Tatsuguchi, K. Ueda, K. Kijima, Y. Nakamura, and Y. Matsuo Development of an orally-administrative MELK-targeting inhibitor that suppresses the growth of various types of human cancer Oncotarget 3 2012 1629 1640
22. A.A. Vagin, and M.N. Isupov Spherically averaged phased translation function and its application to the search for molecules and fragments in electron-density maps Acta. Crystallogr. D Biol. Crystallogr. 57 2001 1451 1456
23. P. Emsley, B. Lohkamp, W.G. Scott, and K. Cowtan Features and development of Coot Acta Crystallogr D BiolCrystallogr 66 2010 486 501
24. P.D. Adams, P.V. Afonine, G. Bunkoczi, V.B. Chen, I.W. Davis, N. Echols, J.J. Headd, L.W. Hung, G.J. Kapral, R.W. Grosse-Kunstleve, A.J. McCoy, N.W. Moriarty, R. Oeffner, R.J. Read, D.C. Richardson, J.S. Richardson, T.C. Terwilliger, and P.H. Zwart PHENIX: a comprehensive Python-based system for macromolecular structure solution Acta Crystallogr D BiolCrystallogr 66 2010 213 221
25. G. Canevari, and S. Re Depaolini, U. Cucchi, J.A. Bertrand, E. Casale, C. Perrera, B. Forte, P. Carpinelli, E.R. Felder, Structural insight into maternal embryonic leucine zipper kinase (MELK) conformation and inhibition toward structure-based drug design Biochemistry 52 2013 6380 6387